Climb Bio, Inc.
CLYM
$1.21
-$0.02-1.63%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1,124.57% | -131.15% | -124.17% | -951.51% | 92.39% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 173.36% | -3.93% | 17,793.33% | 71,664.38% | -94.59% |
| Change in Net Operating Assets | 714.22% | 17.66% | -117.58% | 174.10% | 73.96% |
| Cash from Operations | -748.49% | -483.00% | -316.48% | 91.63% | 88.01% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -410.89% | -245.34% | -356.05% | -212.30% | 137.21% |
| Cash from Investing | -410.89% | -245.34% | -356.05% | -502.44% | 137.21% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 1.04% | 330.11% | 534,908.33% | 1,400.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -85.76% | 330.11% | 534,908.33% | 1,400.00% |
| Foreign Exchange rate Adjustments | 14.29% | 82.73% | 2,600.00% | -95.24% | -112.12% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -588.37% | -264.84% | -340.07% | 1,391.80% | 230.29% |